JPS5849233B2 - Enzyme or bacterial cell immobilized product and method for producing the same - Google Patents
Enzyme or bacterial cell immobilized product and method for producing the sameInfo
- Publication number
- JPS5849233B2 JPS5849233B2 JP9522076A JP9522076A JPS5849233B2 JP S5849233 B2 JPS5849233 B2 JP S5849233B2 JP 9522076 A JP9522076 A JP 9522076A JP 9522076 A JP9522076 A JP 9522076A JP S5849233 B2 JPS5849233 B2 JP S5849233B2
- Authority
- JP
- Japan
- Prior art keywords
- resin
- item
- enzyme
- weight
- cellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000004190 Enzymes Human genes 0.000 title claims description 43
- 108090000790 Enzymes Proteins 0.000 title claims description 43
- 230000001580 bacterial effect Effects 0.000 title claims description 5
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 239000012528 membrane Substances 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- 229920005989 resin Polymers 0.000 claims description 23
- 239000011347 resin Substances 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000001913 cellulose Substances 0.000 claims description 13
- 229920002678 cellulose Polymers 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 13
- 230000000813 microbial effect Effects 0.000 claims description 12
- 235000018102 proteins Nutrition 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 229920000159 gelatin Polymers 0.000 claims description 8
- 239000008273 gelatin Substances 0.000 claims description 8
- 108010010803 Gelatin Proteins 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 229920002433 Vinyl chloride-vinyl acetate copolymer Polymers 0.000 claims description 3
- 239000005018 casein Substances 0.000 claims description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
- 235000021240 caseins Nutrition 0.000 claims description 3
- 239000012461 cellulose resin Substances 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 239000012460 protein solution Substances 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 108010093096 Immobilized Enzymes Proteins 0.000 claims 1
- 229920006026 co-polymeric resin Polymers 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 38
- 238000006243 chemical reaction Methods 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 7
- 238000003756 stirring Methods 0.000 description 6
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- 108700040099 Xylose isomerases Proteins 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- -1 etc.) Proteins 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000001573 invertase Substances 0.000 description 3
- 235000011073 invertase Nutrition 0.000 description 3
- 239000003094 microcapsule Substances 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LONLXRPIYFRSMN-WNQIDUERSA-N (2r)-2-amino-3-sulfanylpropanoic acid;9h-carbazole Chemical compound SC[C@H](N)C(O)=O.C1=CC=C2C3=CC=CC=C3NC2=C1 LONLXRPIYFRSMN-WNQIDUERSA-N 0.000 description 1
- LWFUFLREGJMOIZ-UHFFFAOYSA-N 3,5-dinitrosalicylic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O LWFUFLREGJMOIZ-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241001400590 Richia Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005028 tinplate Substances 0.000 description 1
Landscapes
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Description
【発明の詳細な説明】
本発明は酵素もしくは微生物菌体の固定化物およびその
製造方法、更に詳しくは、酵素もしくは微生物菌体を半
透膜性樹脂膜中に包括して成る固定化物およびその製造
方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an immobilized product of an enzyme or a microbial cell and a method for producing the same, and more specifically, an immobilized product comprising an enzyme or a microbial cell enclosed in a semipermeable resin membrane and the production thereof. Regarding the method.
従来、酵素を固定化して不溶化する方法の一つとして、
半透膜を利用する、いわゆるマイクロカプセル法がある
。Conventionally, one of the methods for immobilizing enzymes and making them insoluble is
There is a so-called microcapsule method that uses a semipermeable membrane.
この方法は半透明性樹脂の皮膜によって酵素を被覆し固
定化する方法であって、得られる酵素マイクロカプセル
は通常、直径数ミクロンから数百ミクロンの球状である
。This method is a method in which enzymes are coated and immobilized with a film of translucent resin, and the resulting enzyme microcapsules are usually spherical with a diameter of several to several hundred microns.
しかし、マイクロカプセル化法では、膜の細孔を調節す
ることが困難であるという大きな欠点があり、酵素種類
が著しく制限される。However, the microencapsulation method has a major drawback in that it is difficult to control the pores of the membrane, which severely limits the types of enzymes that can be used.
また、マイクロカプセル調製中に酵素失活をきたす可能
性がある。Furthermore, enzyme deactivation may occur during microcapsule preparation.
本発明の目的は、かかる酵素固定化法の欠点を解消せし
めた方法、即ち活性低下を低減せしめ且つ広範囲の条件
下で簡易に実施できる新規な包括法により、所望の酵素
固定化物を提供することにある。The purpose of the present invention is to provide a desired enzyme immobilized product by a method that eliminates the drawbacks of such enzyme immobilization methods, that is, by a novel comprehensive method that reduces activity reduction and can be easily carried out under a wide range of conditions. It is in.
本発明者らはこの目的を達成するため鋭意研究を進めた
結果、■半透膜性樹脂、■親水性溶剤、■セルロース微
粉末、■水、■タンパク質水溶液および■酵素から威る
組或物を乾燥フイルムとしたものは高い酵素活性を長期
間保持していることを見出した。As a result of intensive research to achieve this objective, the inventors of the present invention have developed a composition that consists of: ■ semipermeable membrane resin, ■ hydrophilic solvent, ■ fine cellulose powder, ■ water, ■ aqueous protein solution, and ■ enzyme. It was found that a dried film retains high enzyme activity for a long period of time.
また、酵素だけでなく微生物菌体も同様にして固定化で
きることを見出した。Furthermore, we have discovered that not only enzymes but also microbial cells can be immobilized in a similar manner.
本発明は上述の知見に基づいて完戒されたものであって
、その要旨は、■半透膜性樹脂膜中にセルロース微粉末
およびタンパク質と共に酵素もしくは微生物菌体が混在
していることを特徴とする酵素もしくは菌体固定化物、
および■半透膜性樹脂を親水性溶剤に溶解し、これにセ
ルロース微粉末および水を混合した後タンパク質水溶液
を混合し、最後に酵素もしくは微生物菌体の水分散体を
混合し、得られる組或物を膜状にした後乾燥することを
特徴とする上記固定化物の製造方法に存する。The present invention has been developed based on the above-mentioned findings, and its gist is: (1) A semipermeable resin membrane is characterized by a mixture of enzymes or microbial cells together with cellulose fine powder and protein. enzyme or bacterial cell immobilized product,
and ■ Dissolve the semipermeable membrane resin in a hydrophilic solvent, mix it with fine cellulose powder and water, mix it with an aqueous protein solution, and finally mix it with an aqueous dispersion of enzymes or microorganisms. The present invention resides in the above-mentioned method for producing an immobilized product, which comprises forming a film into a film and then drying it.
本発明で対象とする酵素もしくは微生物菌体は、特にそ
の種類に制限はなく、例えば酵素としては加水分解酵素
(アミラーゼ、プロテアーゼ、リパーゼ、ペクチナーゼ
、インベルターゼなど)、酸化還元酵素(グルコースオ
キシダーゼ、カタラーゼなど)、異性化酵素(グルコー
スイソメラーゼなど)等が挙げられる。The enzymes or microorganisms targeted by the present invention are not particularly limited in type; examples of enzymes include hydrolytic enzymes (amylase, protease, lipase, pectinase, invertase, etc.), oxidoreductases (glucose oxidase, catalase, etc.) ), isomerase (glucose isomerase, etc.), and the like.
微生物菌体としてはエシエリヒア・コリ( Esche
richia coli )、ストレプトミセス・ファ
エオク口モゼネス( Strep−tomyces P
haeochromogenes )等が挙げられる。As a microbial cell, Escherichia coli (Escherichia coli)
richia coli), Streptomyces P.
haeochromogenes) and the like.
本発明で用いる半透膜性樹脂としては、半透膜性能を有
し且つ親水性溶剤可溶型のものであればいずれでもよく
、例えばセルロース系樹脂(コロジオン、エチルセルロ
ース系樹脂など)、ポリビニルアルコール系樹脂(ブチ
ラール樹脂など)、塩化ビニルー酢酸ビニル共重合樹脂
等が挙げられ、これら1種もしくは2種以上の混合物で
使用に供する。The semipermeable membrane resin used in the present invention may be any resin that has semipermeable membrane performance and is soluble in a hydrophilic solvent, such as cellulose resin (collodion, ethyl cellulose resin, etc.), polyvinyl alcohol, etc. Examples include resins such as butyral resins, vinyl chloride-vinyl acetate copolymer resins, etc., and these resins may be used alone or as a mixture of two or more thereof.
本発明で用いる親水性溶剤としては、メタノール、エタ
ノール、イソプロビルアルコール、ブタノール、エチレ
ングリコール、ホリエチレンクリコール、グリセリン、
アセトン、メチルエチルケトン等が挙げられ、これら1
種もしくは2種以上の混合物で使用に供する。Examples of the hydrophilic solvent used in the present invention include methanol, ethanol, isopropyl alcohol, butanol, ethylene glycol, polyethylene glycol, glycerin,
Examples include acetone, methyl ethyl ketone, etc.
It can be used as a species or as a mixture of two or more species.
本発明で用いるセルロース微粉末としては、通常の市販
セルロース粉末でよく、また必要に応じて、セルロール
粉末を加えた配合物(但し酵素等は未添加の状態)をホ
モジナイザー等で分散せしめ、微細化せしめたものでも
使用できる。The fine cellulose powder used in the present invention may be any ordinary commercially available cellulose powder, and if necessary, a mixture containing cellulose powder (but without any enzymes, etc.) may be dispersed using a homogenizer or the like to make it fine. You can also use it even if it has been squeezed.
当該セルロース微粉末は粒径50μ以下、好ましくは2
0μ以下のものでよい。The cellulose fine powder has a particle size of 50μ or less, preferably 2
It may be 0 μ or less.
このセルロース微粉末を配合することにより、目的固定
化物における透水性および反応すべき物質の透過性が向
上し、その結果酵素等の反応効率も向上する。By blending this fine cellulose powder, the water permeability of the target immobilized product and the permeability of the substance to be reacted are improved, and as a result, the reaction efficiency of enzymes and the like is also improved.
本発明で用いるタンパク質としては、ゼラチン、カゼイ
ン等の水溶性タンパク質でよく、これを使用することに
より目的固定化物における酵素等の安定化を計ることが
できる。The protein used in the present invention may be a water-soluble protein such as gelatin or casein, and by using this, it is possible to stabilize enzymes, etc. in the target immobilized product.
本発明固定化物を製造するための上記各戒分配合の組成
物は、次の割合で構成されることが望ましい。The composition of each of the above-mentioned precepts for producing the immobilized product of the present invention is preferably composed of the following proportions.
■半透膜性樹脂 3〜10重1那■親水
性溶剤 20〜60 〃■セルロース微
粉末 1〜20//■水
2〜15 〃■10重量俤タンパク質水
溶液 5〜30 〃■酵素(もしくは微生物菌体)0
.01〜5 〃本発明にあっては、上記成分■〜■を番
号に従って順次、充分攪拌しながら混合する。■Semi-permeable membrane resin 3~10w//■Hydrophilic solvent 20~60〃■Cellulose fine powder 1~20//■Water
2-15 〃■10 weight protein aqueous solution 5-30 〃■Enzyme (or microbial cells) 0
.. 01-5 In the present invention, the above-mentioned components (1) to (2) are mixed in order according to the numbers with sufficient stirring.
順序を誤ると、半透膜性樹脂あるいはタンパク質および
酵素等が凝集分離し、目的固定化物が得られなくなる。If the order is incorrect, the semipermeable membrane resin, protein, enzyme, etc. will aggregate and separate, making it impossible to obtain the desired immobilized product.
なお、セルロース微粉末と水の配合順序は入替でもよい
。Note that the order of blending the cellulose fine powder and water may be changed.
このようにして得られる組或物を金属、プラスチック等
の基板上にハケ塗り、流し塗り、ヘラ塗り等適宜な方法
で塗布して膜状となし、これを60℃以下の温度で強制
乾燥、常温乾燥または低温乾燥させることにより、目的
固定化物とすることができる。The composite thus obtained is applied to a substrate such as metal or plastic by an appropriate method such as brush coating, flow coating, spatula coating, etc. to form a film, which is then force-dried at a temperature of 60°C or less. The desired immobilized product can be obtained by drying at room temperature or low temperature.
この固定化物は、弾力性に富み、物理的強度も良好であ
るから、カラムに充填して連続的に酵素(もしくは微生
物菌体)反応に供することができる。Since this immobilized product is highly elastic and has good physical strength, it can be packed into a column and subjected to continuous enzyme (or microbial cell) reactions.
以上の構或から成る本発明によれば、活性低下が少なく
且つ使用範囲の広い所期目的の固定化物を得ることがで
き、以下に示す利点を奏する。According to the present invention having the above-described structure, it is possible to obtain a desired immobilized product that has a small reduction in activity and can be used over a wide range of applications, and has the following advantages.
■ 酵素の固定化が簡便であり、固定化操作中その活性
低下が従来のものに比べ少ない。■ Enzyme immobilization is simple, and the activity decreases less during the immobilization procedure than with conventional methods.
■ 対象とする酵素の種類に制限がほとんどなく、粗酵
素品でも何ら問題なく使用することができる。■ There are almost no restrictions on the type of enzyme to be used, and even crude enzyme products can be used without any problems.
■ 酵素の流出を防止することができ且つ半透膜の透過
性を適当にコントロールすることにより、反応させる物
質の大きさに合わせた固定化物を提供することができる
。(2) By being able to prevent enzyme leakage and appropriately controlling the permeability of the semipermeable membrane, it is possible to provide an immobilized product that matches the size of the substance to be reacted.
■ 酵素だけでなく微生物菌体も同様に固定化すること
ができる。■ Not only enzymes but also microbial cells can be immobilized in the same way.
次に実施例および比較例を挙げて本発明を具体的に説明
する。Next, the present invention will be specifically explained with reference to Examples and Comparative Examples.
実施例 1 下記戒分を準備する。Example 1 Prepare the following precepts.
■エチルセルロース粉末 5fI■エタ
ノール 20グ酢酸エチル
20グイソプロピルアルコール
51■セルロース微粉末
51■水
101■10重量多ゼラチン水溶液 51
■グルコースイソメラーゼ 0.11
以上の或分■〜■を順次配合する。■Ethyl cellulose powder 5fI■Ethanol 20g Ethyl acetate
20gisopropyl alcohol
51■ Cellulose fine powder
51■Wednesday
101 ■ 10 weight multi-gelatin aqueous solution 51
■Glucose isomerase 0.11
The above steps (1) to (2) are sequentially blended.
すなわち成分■を或分■に充分に溶解した後、これに成
分■を加え充分に分散する。That is, after sufficiently dissolving component (2) in a certain amount of (2), component (2) is added thereto and thoroughly dispersed.
分散はホモジナイザーで成分■の粒径が20μ以下にな
るまで行う。Dispersion is carried out using a homogenizer until the particle size of component (1) becomes 20 μm or less.
次に或分■を加え攪拌後、成分■を加え充分に混合する
。Next, add component (2) for a certain amount and stir, then add component (2) and mix thoroughly.
この段階で或分■を加えて均一な組或物を得る。At this stage, add a certain amount of water to obtain a uniform composition.
この組或物をブリキ板に流し塗りし、常温強制乾燥して
固定化膜を得る。This composite is poured onto a tin plate and forcedly dried at room temperature to obtain a fixed film.
上記固定化膜を5〜10mmHに切断し、これを下記組
成の液と共に60℃で30分間にわたり緩慢に攪拌しな
がら反応させ、次いで1/2M−HC10420mlを
加え反応を停止する。The above-mentioned immobilized membrane was cut into pieces of 5 to 10 mmH, and reacted with a solution having the composition shown below at 60°C for 30 minutes with slow stirring, and then 420 ml of 1/2M-HC10 was added to stop the reaction.
反応により生じたフラクトーズ量をシステインー力ルバ
ゾール法により測定する。The amount of fructose produced by the reaction is measured by the cysteine-rubasol method.
組成
30重量係グルコース溶液 10I1ll1
/IOM−リン酸緩衝液(pH7.5 ) 6
orrti1/IOM−硫酸マグネシウム溶液
10Ill純水 101rLl
一方、グルコースイソメラーゼ0.1fを同濃度で用い
て同様に反応せしめ、生じたフラクトーズ量を測定する
。Composition 30 weight glucose solution 10I1ll1
/IOM-phosphate buffer (pH 7.5) 6
orrti1/IOM-Magnesium sulfate solution
10Ill Pure Water 101rLl On the other hand, a similar reaction is carried out using 0.1f of glucose isomerase at the same concentration, and the amount of fructose produced is measured.
この2つの測定結果から、当該不溶化酵素の活性度は不
溶化していないものに比べ41.8優の活性を示す。From these two measurement results, the activity of the insolubilized enzyme is 41.8 times higher than that of the non-insolubilized enzyme.
比較例 1および2
実施例1における固定化膜製造用組成物の成分配合にお
いて、成分■のゼシチン水溶液を配合しない以外は実施
例lと同様にして固定化膜を得る(比較例1)。Comparative Examples 1 and 2 An immobilized membrane is obtained in the same manner as in Example 1, except that the aqueous solution of zecitin (component (2)) is not blended in the composition of the composition for producing an immobilized membrane in Example 1 (Comparative Example 1).
また、同様に成分■のセルロース微粉末を配合しない以
外は実施例1と同様にして固定化膜を得る(比較例2)
。Further, an immobilized membrane was obtained in the same manner as in Example 1 except that the cellulose fine powder of component (①) was not blended (Comparative Example 2).
.
得られる両比較例の固定化膜を用いて、実施例1と同様
に酵素反応に付すと、不溶化酵素の活性度は不溶化して
いないものに比べて、比較例1の場合で10.3%、比
較例2の場合で16.8%の活性を示す。When the resulting immobilized membranes of both Comparative Examples were subjected to an enzymatic reaction in the same manner as in Example 1, the activity of the insolubilized enzyme was 10.3% in Comparative Example 1 compared to that without insolubilization. , Comparative Example 2 shows an activity of 16.8%.
実施例 2 下記成分を準備する。Example 2 Prepare the following ingredients.
■ブチラール樹脂粉末 51■エタノ
ール 20?アセトン
20グポリエチレングリコール
5グ■セルロース微粉末
5t■水
ioy■10重量饅ゼラチン水溶液 51■
グルコースイソメラーゼ 0.1?以
上の戒分■〜■を使用し実施例1と同様にして固定化膜
を得る。■Butyral resin powder 51 ■Ethanol 20? acetone
20g polyethylene glycol
5g■ Cellulose fine powder
5t water
ioy■10 weight steamed gelatin aqueous solution 51■
Glucose isomerase 0.1? An immobilized membrane was obtained in the same manner as in Example 1 using the above precepts ① to ②.
その活性を実施例1と同様に測定した結果、当該不溶化
酵素の活性度は不溶化していないものに比べ38.9%
の活性を示す。As a result of measuring its activity in the same manner as in Example 1, the activity of the insolubilized enzyme was 38.9% compared to that of the non-insolubilized enzyme.
activity.
実施例 3 下記成分を準備する。Example 3 Prepare the following ingredients.
■塩化ビニルー酢酸ビニル共重合樹脂 5グ■エタ
ノール 2oグアセトン
20?イソプロビルアルコール
5L?■セルロース微粉末
51■水
1oグ■10重量係ゼラチン水溶液 5
10■インベルターゼ 0.1f
t以上の威分■〜■を使用し実施例1と同様にして固定
化膜を得る。■Vinyl chloride-vinyl acetate copolymer resin 5g ■Ethanol 2o Guacetone
20? isoprobyl alcohol
5L? ■Cellulose fine powder
51■Wednesday
1og ■10 weight gelatin aqueous solution 5
10 ■ Invertase 0.1f
An immobilized membrane was obtained in the same manner as in Example 1 using the weight ratios (1) to (2) of t or more.
これを5〜10mm幅に切断し、下記組或の液と共に4
0℃で30分間にわたり緩慢に攪拌しながら反応させる
。Cut this into 5-10mm wide pieces and mix with the following solution.
React at 0° C. for 30 minutes with slow stirring.
反応により生じた還元糖量をウイルシュテツター−シュ
ーデル法により測定する。The amount of reducing sugar produced by the reaction is measured by the Wilstadter-Schudel method.
組戒
10重量ダショ糖液 101′fLl
1/2 5 M−クエン酸/リン酸緩衝液(pH3.8
) 8 0rrLl一方、インベルターゼ0.11を
同濃度で用いて同様に反応せしめ、生じた還元糖量を測
定する。Kumikai 10 weight dosucrose solution 101'fLl
1/2 5 M citric acid/phosphate buffer (pH 3.8
) 80rrLl On the other hand, a similar reaction is carried out using invertase 0.11 at the same concentration, and the amount of reducing sugar produced is measured.
この2つの測定結果から、当該不溶化酵素の活性度は不
溶化していないものに比べ49.2%の活性を示す。From these two measurement results, the activity of the insolubilized enzyme is 49.2% compared to that of the non-insolubilized enzyme.
実施例 4 下記或分を準備する。Example 4 Prepare the following.
■ブチラール樹脂粉末 51■エタノ
ール 20rアセトン
20グポリエチレングリコール
51■セルロース微粉末
8t■10重量係ゼラチン水溶液
6f?■α−アミラーゼ 0.11
以上の戒分■〜■を使用し実施例1と同様にして固定化
膜を得る。■Butyral resin powder 51 ■Ethanol 20r acetone
20g polyethylene glycol
51■ Cellulose fine powder
8t ■ 10 weight gelatin aqueous solution
6f? ■α-amylase 0.11
An immobilized membrane was obtained in the same manner as in Example 1 using the above precepts ① to ②.
これを5〜10關幅に切断し、下記組成の液と共に40
℃で30分間にわたって緩慢に攪拌しながら反応させる
。This was cut into 5 to 10 square pieces, and 40
The reaction is allowed to proceed at 0.degree. C. for 30 minutes with slow stirring.
組或
可溶性デンプン Is’レ’5
0 M−リン酸緩衝液(pH6.9 )
9 0 1′rLl上記反応液に3,5−ジニトロサリ
チル酸溶液50rlLlを加え反応を停止する。Soluble starch Is're'5
0 M phosphate buffer (pH 6.9)
9 0 1'rLl 50rLl of 3,5-dinitrosalicylic acid solution was added to the above reaction solution to stop the reaction.
この反応液を10m.l取り、沸騰浴中に5分間漬け、
次いで流水で冷却した後純水10rrLlを加え、生じ
た還元糖量を光電比色計で測定する。This reaction solution was heated to 10 m. Take one, soak it in a boiling bath for 5 minutes,
Next, after cooling with running water, 10 rrLl of pure water was added, and the amount of reducing sugar produced was measured using a photoelectric colorimeter.
一方、α−アミラーゼ0.11を同濃度で用いて同様に
反応せしめ、生じた還元糖量を測定する。On the other hand, a similar reaction is carried out using α-amylase 0.11 at the same concentration, and the amount of reducing sugar produced is measured.
この2つの測定結果から、当該不溶化酵素の活性度は不
溶化していないものに比べ46.7%の活性を示す。From these two measurement results, the activity of the insolubilized enzyme is 46.7% compared to that of the non-insolubilized enzyme.
実施例 5 下記成分を準備する。Example 5 Prepare the following ingredients.
■ブチラール樹脂粉末 81■エタノ
ール 20fアセトン
20fグリセリン
51
■セルロース微粉末 8グ■10
重量係ゼラチン水溶液 6t■ストレプトミ
セス・ファエオク口モゼネス(菌体を凍結乾燥後融解し
アセトン脱 1i水したもの)
以上の成分■〜■を使用し実施例1と同様にして固定化
膜を得る。■Butyral resin powder 81 ■Ethanol 20f acetone
20f glycerin
51 ■Cellulose fine powder 8g■10
Aqueous gelatin solution by weight: 6 t Streptomyces faeokuchi mozenes (microbial cells lyophilized, thawed, and dehydrated with acetone) An immobilized membrane was obtained in the same manner as in Example 1 using the above components 1 to 2.
これを5〜10m111幅に切断し、下記組或の液と共
に60℃で30分間にわたって緩慢に攪拌しながら反応
させ、次いで
1/2M−HC 1042 0 rrtlを加え反応を
停止する。This was cut into a width of 5 to 10 ml and reacted with the following solution at 60° C. for 30 minutes with slow stirring, and then 1/2M-HC 10420 rrtl was added to stop the reaction.
反応により生じたフラクトーズ量をシステインーカルバ
ゾτル法により測定する。The amount of fructose produced by the reaction is measured by the cysteine-carbazole method.
組成
30重量係グルコース溶液 10縦1/IO
M−リン酸緩衝液(pI{7.5) 6011
Ll1/IOM−硫酸マグネシウム溶液 1om
l純水1o771l
一方、菌体11を同濃度で用いて同様に反応せしめ、生
じたフラクトーズ量を測定する。Composition 30 weight ratio Glucose solution 10 vertical 1/IO
M-phosphate buffer (pI{7.5) 6011
Ll1/IOM-Magnesium sulfate solution 1om
1 771 liters of pure water On the other hand, the same concentration of bacterial cells 11 was used to react in the same manner, and the amount of fructose produced was measured.
この2つの測定結果から、当該不溶化菌体の活性度は不
溶化していないものに比べ4 3. 1 q6の活性を
示す。From these two measurement results, the activity of the insolubilized bacterial cells is 4.3 compared to that of non-insolubilized cells. 1 Indicates q6 activity.
Claims (1)
ク質と共に酵素もしくは微生物菌体が混在していること
を特徴とする酵素もしくは菌体固定化物。 2 半透膜性樹脂がセルロース系樹脂、ポリビニルアル
コール系樹脂および塩化ビニルー酢酸ビニノν共重合樹
脂から選ばれる少なくとも1種である上記第1項記載の
物。 3 タンパク質がゼラチンおよびカゼインから選ばれる
少なくとも1種である上記第1項記載の物。 4 半透膜性樹脂を親水性溶剤に溶解し、これにセルロ
ース微粉末および水を混合した後タンパク質水溶液を混
合し、最後に酵素もしくは微生物菌体の水分散体を混合
し、得られる組或物を膜状にした後乾燥することを特徴
とする酵素もしくは菌体固定化物の製造方法。 5 組戒物が半透膜性樹脂3〜10重量係、親水性溶剤
20〜60重量係、セルロース微粉末1〜20重量係、
水2〜15重量係、10〜30重量多のタンパク質水溶
液5〜30重量係および酵素もしくは微生物菌体0.0
1〜5重量係の割合から成る上記第4項記載の方法。 6 半透膜性樹脂としてセルロース系樹脂、ポリビニル
アルコール系樹脂および塩化ビニルー酢酸ビニル共重合
樹脂から選ばれる少なくとも1種を使用する上記第4項
または第5項記載の方法。 7 親水性溶剤としてメタノール、エタノール、イソプ
ロビルアルコール、ブタノール、エチレングリコール、
ポリエチレングリコール、グリセリン、アセトンおよび
メチルエチルケトンから選ばれる少なくとも1種を使用
する上記第4項または第5項記載の方法。 8 タンパク質としてゼラチンおよびカゼインから選ば
れる少なくとも1種を使用する上記第4項または第5項
記載の方法。 9 半透膜性樹脂の親水性溶剤溶液へのセルロース微粉
末と水の混合を、いずれか一方を先に混合した後他方を
混合することによって実施する上記第4項記載の方法。 10組或物を膜状にするのにハケ塗り、流し塗りまたは
ヘラ塗りを採用する上記第4項記載の方法。 11 乾燥を60℃以下の温度での強制乾燥、常温乾燥
または低温乾燥で行う上記第4項記載の方法。[Scope of Claims] 1. An enzyme or microbial cell immobilized product characterized in that enzymes or microbial cells are mixed together with cellulose fine powder and protein in a semipermeable resin membrane. 2. The product according to item 1 above, wherein the semipermeable membrane resin is at least one selected from cellulose resins, polyvinyl alcohol resins, and vinyl chloride-vinino acetate v copolymer resins. 3. The product according to item 1 above, wherein the protein is at least one selected from gelatin and casein. 4 Dissolve the semipermeable membrane resin in a hydrophilic solvent, mix it with fine cellulose powder and water, mix it with an aqueous protein solution, and finally mix it with an aqueous dispersion of enzymes or microorganisms. A method for producing an immobilized enzyme or bacterial cell, which comprises forming the material into a film and then drying it. 5. The combination of semipermeable membrane resin 3 to 10 weight, hydrophilic solvent 20 to 60 weight, cellulose fine powder 1 to 20 weight,
Water 2-15% by weight, 10-30% protein aqueous solution 5-30% by weight, and enzyme or microbial cells 0.0%
5. The method of claim 4, comprising a ratio of 1 to 5 parts by weight. 6. The method according to item 4 or 5 above, wherein at least one selected from cellulose resin, polyvinyl alcohol resin, and vinyl chloride-vinyl acetate copolymer resin is used as the semipermeable membrane resin. 7. Hydrophilic solvents include methanol, ethanol, isopropyl alcohol, butanol, ethylene glycol,
The method according to item 4 or 5 above, wherein at least one selected from polyethylene glycol, glycerin, acetone and methyl ethyl ketone is used. 8. The method according to item 4 or 5 above, wherein at least one kind selected from gelatin and casein is used as the protein. 9. The method according to item 4 above, wherein the cellulose fine powder and water are mixed into the hydrophilic solvent solution of the semipermeable membrane resin by mixing either one first and then the other. 10. The method according to item 4 above, wherein brush coating, flow coating, or spatula coating is employed to form a film on the 10 sets. 11. The method according to item 4 above, wherein the drying is performed by forced drying at a temperature of 60° C. or lower, normal temperature drying, or low temperature drying.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9522076A JPS5849233B2 (en) | 1976-08-09 | 1976-08-09 | Enzyme or bacterial cell immobilized product and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9522076A JPS5849233B2 (en) | 1976-08-09 | 1976-08-09 | Enzyme or bacterial cell immobilized product and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5320485A JPS5320485A (en) | 1978-02-24 |
JPS5849233B2 true JPS5849233B2 (en) | 1983-11-02 |
Family
ID=14131648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9522076A Expired JPS5849233B2 (en) | 1976-08-09 | 1976-08-09 | Enzyme or bacterial cell immobilized product and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5849233B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02108929A (en) * | 1988-09-12 | 1990-04-20 | Instruments Sa | Double spectrographic device |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3136695A1 (en) * | 1981-09-16 | 1983-06-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | DEVICE FOR DETECTING MICROORGANISM INHIBITING SUBSTANCES |
-
1976
- 1976-08-09 JP JP9522076A patent/JPS5849233B2/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02108929A (en) * | 1988-09-12 | 1990-04-20 | Instruments Sa | Double spectrographic device |
Also Published As
Publication number | Publication date |
---|---|
JPS5320485A (en) | 1978-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1088009A (en) | Immobilized enzymes as well as their production and use | |
DE2633259A1 (en) | PROCESS FOR THE PRODUCTION OF IMMOBILIZED ENZYMES | |
Akertek et al. | Characterization of immobilized catalases and their application in pasteurization of milk with H2O2 | |
US3972776A (en) | Preparation of protein membranes containing microbial cells | |
JPS60120987A (en) | Production of immobilized microbial cell or enzyme | |
Dickensheets et al. | Characteristics of yeast invertase immobilized on porous cellulose beads | |
JPH0249710B2 (en) | ||
DE3438960C2 (en) | ||
JPS5849233B2 (en) | Enzyme or bacterial cell immobilized product and method for producing the same | |
Handa et al. | The effect of methylacrylate on the activity of glucomylase immobilized on granular polyacrylonitrile | |
JPS6228679B2 (en) | ||
DE2553649A1 (en) | METHOD FOR CARRYING OUT ENZYMATIC REACTIONS | |
Arslan et al. | The effect of gel composition on the adsorption of invertase on poly (acrylamide/maleic acid) hydrogels | |
Bihari et al. | Studies on immobilized fungal spores for microbial transformation of steroids: 11 α‐Hydroxylation of progesterone with immobilized spores of Aspergillus ochraceus G8 on polyacrylamide gel and other matrices | |
Ooshima et al. | Characteristics of immobilized invertase | |
Elçin et al. | Urease immobilization into poly (acrylamide)-gelatin gels | |
CA1319632C (en) | Method for microbial immobilization | |
Melo et al. | Ocimum basilicum seeds as a pellicular support for immobilizing enzymes | |
JPS5851758B2 (en) | Enzyme or bacterial cell immobilized product and method for producing the same | |
Hoshino et al. | A study on the thermostability of microencapsulated glucose oxidase | |
SU1130598A1 (en) | Method for preparing immobilized oxydoreductases | |
JPH01313530A (en) | Preparation of silk fibroin powder | |
DD294729A5 (en) | PROCESS FOR THE PRODUCTION OF IMMOBILISATES WITH BIOLOGICALLY ACTIVE, MACROMOLECULAR COMPOUNDS | |
Kusaoke et al. | Immobilization of α-amylase on glycolchitosan | |
DE1935711C3 (en) | Water-insoluble protein. Eliminated from: 1908290 |